| Acne |
No |
| Active substance |
Betamethasone |
| Also known as |
Betamethasone sodium phosphate, Betamethasone acetate |
| Aromatization |
No |
| Blood pressure |
Can increase blood pressure, monitoring advised |
| Chemical name |
9-fluoro-11ОІ,17,21-trihydroxy-16ОІ-methylpregna-1,4-diene-3,20-dione |
| Classification |
anti-inflammatory |
| Dosage (medical) |
Dosage varies, typical initial dosages may range from 0.6 to 7.2 mg daily depending on the condition being treated |
| Dosage (sports) |
Not applicable for performance enhancement as its use is generally for medical treatment only |
| Effects |
Reduces inflammation, suppresses the immune response |
| Formula |
C22H29FO5 |
| Half-life |
36-54 hours |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Monitoring may include adrenal function tests and bone density scans for long-term users |
| Main action |
Anti-inflammatory and immunosuppressant |
| Side effects |
Long-term use can lead to side effects like osteoporosis, adrenal suppression, muscle weakness, ulcerative esophagitis, and psychological effects such as mood swings |
| Storage conditions |
Store at controlled room temperature, away from light and moisture |
| Substance class |
Corticosteroid |
| Trade name |
Celestone, Betnesol, others |
| Use in sports |
Primarily used for therapeutic purposes to treat inflammation and manage symptoms of chronic conditions |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
GSK |
